Taiwanese Pharma Co. Fights AOP Orphan's Sanctions Bid

By Madeline Lyskawa · October 19, 2021, 6:02 PM EDT

Taiwanese pharmaceutical company PharmaEssentia has told a Massachusetts federal judge that despite its immense cooperation with discovery requests, Austrian pharmaceutical company AOP Orphan has "aggressively" sought sanctions for a single document...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Response

Case Information

Case Title

AOP Orphan Pharmaceuticals AG v. Pharmaessentia Corporation

Case Number

Court

Massachusetts

Nature of Suit

Other Statutes: Arbitration

Date Filed

November 19, 2020

Recent Articles By Madeline

May 05, 2025
UnitedHealth Tells Court Not To Review Special Master Report
April 25, 2025
DOD To Assess Tricare Program Competition In Ga. And Fla.
April 18, 2025
DOJ Accuses Uniform Supplier Of Dodging Customs Duties
April 10, 2025
GAO Tells DOD To Address Medical Facility Staffing
March 20, 2025
Texas Says Planned Parenthood Can't Get Atty Immunity
March 11, 2025
Software Co. Tells Fed. Circ. It's Owed Over $12.7M In IP Dispute
February 19, 2025
Tech Co.'s Software Doesn't Meet CMS Needs, Judge Says
February 03, 2025
Allergan Tells 4th Circ. Medicaid Pricing Suit Rightly Tossed
January 24, 2025
5th Circ. Upholds Tossing Medicare Rate Policy Challenge
January 16, 2025
Texas Judge Says 3 States Can Pursue Mifepristone Suit